Zeto EEG

Zeto EEG offers a comprehensive, FDA-cleared platform for electroencephalography (EEG) monitoring, designed for both critical care and outpatient environments. The system utilizes gel-free, portable EEG headsets that enable rapid setup and extended recording capabilities. This innovative approach addresses the challenges of traditional EEG by providing a more accessible and efficient solution for neurological assessment.

A core feature of the Zeto EEG platform is its AI-powered NeuroPulse™ software, which provides real-time seizure burden and Status Epilepticus detection. This capability is particularly valuable in critical care settings like ICUs and emergency departments, where timely identification of seizure activity is crucial for patient management. The system also includes live video integration, allowing clinicians to correlate EEG data with patient behavior.

Zeto offers two primary products: Zeto ONE, optimized for critical care with extended recording, and Zeto New Wave™, designed for outpatient EEGs up to 2.5 hours. Both systems aim to simplify EEG procedures, making them easier to use for healthcare providers and more comfortable for patients. The platform also generates NeuroNotis™ reports, which are reviewed by R. EEG T. professionals, providing comprehensive clinical value.

The company emphasizes its commitment to evidence-driven research, with an active research pipeline exploring applications in healthcare access, continuous EEG implementation, and optimizing emergency stroke transport strategies using EEG-based biomarkers and machine learning.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist